Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Sep 02, 2020

Axonics® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9

Aug 06, 2020

Axonics® Reports Second Quarter 2020 Results

Jul 27, 2020

Axonics® Announces 2-Year Topline Clinical Results from ARTISAN-SNM Pivotal Study

Jul 16, 2020

Axonics® to Report Second Quarter 2020 Results on August 6

Jul 13, 2020

Axonics® Reports Preliminary Second Quarter 2020 Revenue

Jul 01, 2020

Axonics® Receives FDA Approval for 3T Full-Body MRI Scans

Jun 03, 2020

Axonics® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology

May 19, 2020

Axonics® ARTISAN Results Published Demonstrating Continued Therapy Response and Patient Satisfaction at 1-year

May 12, 2020

Axonics® Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock

May 07, 2020

Axonics® Announces Pricing of Public Offering of Common Stock

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Next page
Last page

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

©2020 Axonics Modulation Technologies, Inc. Axonics^® and Axonics Modulation Technologies^® are trademarks of Axonics Modulation Technologies, Inc., registered or pending registration in the U.S. and other countries.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap